CRESCI, BARBARA
 Distribuzione geografica
Continente #
NA - Nord America 2.927
EU - Europa 1.562
AS - Asia 1.204
SA - Sud America 166
AF - Africa 30
OC - Oceania 18
Totale 5.907
Nazione #
US - Stati Uniti d'America 2.897
RU - Federazione Russa 677
SG - Singapore 338
CN - Cina 261
HK - Hong Kong 242
PL - Polonia 224
IE - Irlanda 150
VN - Vietnam 140
BR - Brasile 136
SE - Svezia 130
IT - Italia 97
KR - Corea 86
DE - Germania 80
FR - Francia 65
FI - Finlandia 51
IN - India 34
JO - Giordania 28
UA - Ucraina 27
GB - Regno Unito 26
AU - Australia 17
CA - Canada 14
ID - Indonesia 12
AR - Argentina 11
MX - Messico 11
TR - Turchia 10
BD - Bangladesh 9
IQ - Iraq 9
CH - Svizzera 8
EC - Ecuador 8
ES - Italia 8
NG - Nigeria 7
NL - Olanda 7
ZA - Sudafrica 7
JP - Giappone 5
UZ - Uzbekistan 5
BE - Belgio 4
CI - Costa d'Avorio 4
CO - Colombia 4
MA - Marocco 4
PK - Pakistan 4
AE - Emirati Arabi Uniti 3
AM - Armenia 3
CL - Cile 3
DZ - Algeria 3
LT - Lituania 3
PH - Filippine 3
ET - Etiopia 2
IL - Israele 2
JM - Giamaica 2
MY - Malesia 2
NP - Nepal 2
PT - Portogallo 2
TN - Tunisia 2
UY - Uruguay 2
AT - Austria 1
AZ - Azerbaigian 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
HN - Honduras 1
HR - Croazia 1
IR - Iran 1
KE - Kenya 1
KH - Cambogia 1
MM - Myanmar 1
NZ - Nuova Zelanda 1
PY - Paraguay 1
SA - Arabia Saudita 1
SV - El Salvador 1
TW - Taiwan 1
VE - Venezuela 1
Totale 5.907
Città #
Santa Clara 631
Ashburn 318
Fairfield 275
Singapore 249
Warsaw 222
Hong Kong 206
Chandler 173
Dublin 150
Seattle 114
Cambridge 110
Woodbridge 102
Wilmington 99
Houston 96
Seoul 86
San Jose 78
Beijing 72
Buffalo 55
Ho Chi Minh City 46
Ann Arbor 43
Jacksonville 40
Munich 38
Princeton 37
The Dalles 35
Lauterbourg 34
Lawrence 32
Los Angeles 32
Altamura 31
Hanoi 30
Dallas 29
Hefei 27
Boston 26
Kent 26
Florence 23
New York 23
Moscow 20
Mumbai 20
Shanghai 19
Paris 18
Boardman 17
Melbourne 17
Medford 16
Turku 15
San Diego 14
São Paulo 14
Orem 12
Helsinki 11
Council Bluffs 10
Bern 8
Philadelphia 8
Rio de Janeiro 8
Rome 8
Falls Church 7
Frankfurt am Main 7
Milan 7
Redondo Beach 7
Abuja 6
Andover 6
Clifton 6
Dong Ket 6
Izmir 6
Jakarta 6
Phoenix 6
San Francisco 6
Baghdad 5
Chennai 5
Falkenstein 5
Mexico City 5
Tokyo 5
Abidjan 4
Belo Horizonte 4
Brasília 4
Brussels 4
Charlotte 4
Da Nang 4
Haiphong 4
Montreal 4
Tashkent 4
Tianjin 4
Toronto 4
West Jordan 4
Biên Hòa 3
Chicago 3
Columbus 3
Curitiba 3
Frankfurt Am Main 3
Glen Burnie 3
Guayaquil 3
Hillsboro 3
Johannesburg 3
Ottawa 3
Poplar 3
Querétaro 3
Quito 3
Quảng Ngãi 3
Salvador 3
Selvazzano Dentro 3
Semarang 3
Yerevan 3
Addis Ababa 2
Amman 2
Totale 4.030
Nome #
Fit and motivated: outcome predictors in patients starting a program for lifestyle change. 310
False and true pre-treatment predictors of weight loss in obese patients starting a program for lifestyle change. 233
Platelet-activating factor enhances production of insulin-like growth factor binding proteins in a human adenocarcinoma cell line (HEC-1A) 231
Lower and higher-potency statins on glycemic control in type 2 diabetes: A retrospective cohort study 215
Are psychopathological features relevant predictors of glucose control in patients with type 2 diabetes? A prospective study 211
Relationship between GLP-1 levels and dipeptidyl peptidase-4 activity in different glucose tolerance conditions. 190
Reply to Josef Finsterer “MELAS requires broad clinical and genetic work-up” 180
Diabetic microangiopathy: IGFBP control endothelial cell growth by a common mechanism in spite of their species specificity and tissue peculiarity. 177
Group versus individual cognitive-behavioral treatment for obesity: Results after 36 months 168
EFFECTS OF INSULIN AND GLUCOSE ON THE GROWTH AND THE RELEASE OF EXTRACELLULAR-MATRIX COMPONENTS BY BOVINE BONE ENDOTHELIAL-CELLS 163
Failure to metformin and insulin secretagogue monotherapy: an observational cohort study. 162
Insulin resistance and obesity affect monocyte-derived dendritic cell phenotype and function 161
Bone fractures and hypoglycemic treatment in type 2 diabetic patients: a case-control study. 161
Liver enzymes and risk of diabetes and cardiovascular disease: results of the Firenze Bagno a Ripoli (FIBAR) study. 160
All roads bring to Rome: a different way for predicting success in the therapy of obesity through psychological features 159
Hyperparathyroidim: Is It Really the Major Factor Affecting Glucose Tolerance in Uremia. 156
Metabolic surgery for the treatment of type 2 diabetes: A network meta-analysis of randomized controlled trials 154
Therapeutic options in a patient with MELAS and diabetes mellitus: follow-up after 6 months of treatment 152
Body mass index (BMI), waist circumference (WC), waist-to-height ratio (WHtR) e waist body mass index (wBMI): Which is better? 152
Treatment with insulin secretagogues and cancer-related mortality in type 2 diabetic patients a retrospective cohort study. 151
Inflammation markers and metabolic characteristics of subjects with 1-h plasma glucose levels. 150
Glomerular hyperfiltration and metabolic syndrome: results from the FIrenze-BAgno A Ripoli (FIBAR) Study 148
Effectiveness of intermittent fasting for weight loss in individuals with obesity: A meta-analysis of randomized controlled trials 146
Obesity as a risk factor for hospitalization in COronaVirus Disease-19 (COVID-19) patients: Analysis of the Tuscany regional database 145
Efficacy and effects of bariatric surgery in the treatment of obesity: Network meta-analysis of randomized controlled trials 138
Effectiveness of Low Carbohydrate diets for long-term weight loss in obese individuals: a meta-analysis of randomized controlled trials 138
Safety issues with glucagon-like peptide-1 receptor agonists (pancreatitis, pancreatic cancer and cholelithiasis): Data from randomized controlled trials 137
Interstitial glucose monitoring, type 1 diabetes and COVID-19 vaccine: the patient-reported outcomes and vaccine-associated changes in glucose and side effects (PRO-VACS) 136
Online group lifestyle modification programs for obesity during the COVID-19 pandemic: The EDucation ONline (EDON) retrospective study 135
Doses of insulin and its analogues and cancer occurence in insulin-treated type 2 diabetic patients. 133
Motivational readiness for treatment in weight control programs: the treatment motivation and readiness (tre-more) test 123
Inflammation markers and metabolic characteristic of subjects with one-hour plasma glucose levels 116
Motivational readiness to change in lifestyle modification programs 115
National Cholesterol Education Program and International Diabetes Federation definitions of metabolic syndrome in the prediction of diabetes. Results from the FIrenze-Bagno A Ripoli study. 114
Obesity therapy: How and why? 112
Factor analysis as a tool to explore the heterogeneity of type 2 diabetes: A feasibility study 103
Glucagon-like peptide 1 (GLP1) receptor agonists and risk for ischemic optic neuropathy: A meta-analysis of randomised controlled trials 102
MANAGEMENT OF HYPERGLICEMIA IN TYPE 2 DIABETES: A CONSENSUS ALGORITHM FOR THE INITIATION AND ADJUSTMENT OF THERAPY: A CONSENSUS STATEMENT FROM THE AMERICAN DIABETES ASSOCIATION AND THE EUROPEAN ASSOCIATION FOR THE STUDY OF DIABETES 97
Totale 5.934
Categoria #
all - tutte 16.438
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.438


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202147 0 0 0 0 0 0 0 0 0 0 27 20
2021/2022245 7 15 19 7 14 12 5 12 13 17 51 73
2022/2023665 61 122 28 59 41 121 81 20 101 3 15 13
2023/2024270 12 34 41 9 12 33 16 58 3 16 28 8
2024/20251.876 66 194 130 290 507 268 27 152 56 57 74 55
2025/20261.610 228 229 157 114 221 79 216 91 108 114 53 0
Totale 5.934